Diovan and Intertrigo - a phase IV clinical study of FDA data

Summary:

Intertrigo is reported as a side effect among people who take Diovan (valsartan), especially for people who are female, 60+ old, also take Nexium, and have Osteoporosis.

The phase IV clinical study analyzes which people have Intertrigo when taking Diovan. It is created by eHealthMe based on reports of 80,750 people who have side effects when taking Diovan from the FDA, and is updated regularly.

What is Diovan?

Diovan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 83,153 Diovan users. Check the latest studies of Diovan.

What is Intertrigo?

Intertrigo (inflammation (rash) of the body folds (adjacent areas of skin)) is found to be associated with 156 drugs and 213 conditions by eHealthMe. Check the latest studies of Intertrigo.

On Jul, 20, 2026

80,750 people reported to have side effects when taking Diovan.
Among them, 14 people (0.02%) have Intertrigo.

Among these 14 people:

What is the gender of people who have Intertrigo when taking Diovan? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Intertrigo when taking Diovan? *

What are other drugs people take besides Diovan? *

What are other side effects people have besides Intertrigo? *

Urinary Tract Infection: 13 people, 92.86%
Osteonecrosis Of Jaw (death of bone of jaw): 12 people, 85.71%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 12 people, 85.71%
Facial Pain: 11 people, 78.57%
Fall: 9 people, 64.29%
Pain: 9 people, 64.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 64.29%
Joint Swelling: 9 people, 64.29%
Osteopenia (a condition where bone mineral density is lower than normal): 9 people, 64.29%
Oedema Peripheral (superficial swelling): 9 people, 64.29%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 12 people, 85.71%
Osteopenia (a condition where bone mineral density is lower than normal): 4 people, 28.57%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 1 person, 7.14%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 7.14%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.14%
Metastatic Neoplasm (spreadable cancer tumour): 1 person, 7.14%
Metastases To Bone (cancer spreads to bone): 1 person, 7.14%
Hypersensitivity: 1 person, 7.14%
Diabetes: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Diovan and have Intertrigo?

- Check whether Intertrigo is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diovan:

Diovan (83,153 reports)

Intertrigo treatments and more:

Intertrigo (1,057 reports)

Browse all side effects of Diovan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intertrigo:

Intertrigo (156 drugs)

Browse all the conditions that are associated with Intertrigo:

Intertrigo (213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on valsartan (the active ingredients of Diovan) and Diovan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.